Enpp-1-IN-1

CAS No. 2289728-58-9

Enpp-1-IN-1( —— )

Catalog No. M21114 CAS No. 2289728-58-9

Enpp-1-IN-1 is an inhibitor of Ectonucleotide pyrophosphatase-phosphodiesterase 1 (enpp-1) .

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 260 Get Quote
10MG 410 Get Quote
25MG 678 Get Quote
50MG 954 Get Quote
100MG 1287 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Enpp-1-IN-1
  • Note
    Research use only, not for human use.
  • Brief Description
    Enpp-1-IN-1 is an inhibitor of Ectonucleotide pyrophosphatase-phosphodiesterase 1 (enpp-1) .
  • Description
    Enpp-1-IN-1 is an inhibitor of Ectonucleotide pyrophosphatase-phosphodiesterase 1 (enpp-1) .
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    enpp-1
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2289728-58-9
  • Formula Weight
    343.4
  • Molecular Formula
    C17H17N3O3S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:250 mg/mL?(728.01 mM)
  • SMILES
    COc1ccc2c(-c3ccc(CNS(N)(=O)=O)cc3)ccnc2c1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • VIR-165

    VIR-165 is a modified form of virus inhibitory peptide (VIRIP), which corresponds to residues 353 to 372 of C-proximal region of human alpha1-antitrypsin, the most abundant circulating serine protease inhibitor. VIRIP inhibits a wide variety of human immunodeficiency virus type 1 (HIV-1) strains.

  • Laurocapram

    Laurocapram is a percutaneous enhancer. Upon application to the skin, laurocapram interacts with lipids in the stratum corneum and may enhance the ability of the skin to absorb a hydrophilic chemical.

  • Urelumab

    Urelumab(BMS-66513) is a humanized IgG4 monoclonal antibody, often used as a CD137 agonist.